6 points, SCA Band 2, 0.125 EFTSL
Undergraduate - Unit
Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.
PAC2412 Integrated therapeutics: Introduction and cardiovascular
PAC2182 Basis of drug action II
This unit provides a foundation of basic knowledge required for the diagnosis and management of patients with respiratory and gastrointestinal diseases. This unit will relate the pathophysiology of these disorders with the rational design and clinical use of drugs. The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.
This will involve the study of:
- pathophysiology of respiratory diseases
- chemistry of drugs used in respiratory diseases
- pharmacology of drugs used in respiratory diseases
- respiratory disease state management
- pathophysiology of gastrointestinal diseases
- chemistry of drugs used in gastrointestinal diseases
- pharmacology of drugs used in gastrointestinal diseases
- gastrointestinal disease state management.
At the end of this unit students will be able to:
- Describe the epidemiology and concepts of disease state management of respiratory and gastrointestinal diseases;
- Describe the normal function of the respiratory and gastrointestinal systems, and the signs and symptoms likely to be seen in patients with respiratory and gastrointestinal disorders;
- Appraise when referral for medical assessment is required, with a particular emphasis on symptoms indicative of referral;
- Reflect on their primary care response to symptoms, communication and counselling skills with respect to the supply of non-prescription medicines used for respiratory and gastrointestinal diseases;
- Describe the chemistry of the different types of drugs used to treat respiratory and gastrointestinal disorders and the chemical and biological principals behind the development of a range of drugs used to treat these disorders;
- Examine the mechanism of action of drugs used in treatment of gastrointestinal disease, and appreciate how this leads to the treatment of disease, as well as side effects produced;
- Demonstrate how drug and non-drug therapy options for the management of respiratory and gastrointestinal diseases contribute to primary and secondary prevention strategies for respiratory and gastrointestinal diseases;
- Evaluate a patient's respiratory and/or gastrointestinal disease state, identify any drug therapy problems and recommend appropriate resolutions of those problems.
Final exam (2 hour): 60%; on-going assessments: 40%.
Contact hours for on-campus students:
- The equivalent of thirty six 1-hour lectures
- Three 3-hour tutorials
See also Unit timetable information